Pursuant to Regulation 47 of the SEBI(LODR) Regulations, 2015, please find enclosed copies of the newspaper advertisement pertaining Unaudited Financial Results of the Company for the Quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) Limited submitted copies of newspaper advertisements containing its unaudited financial results for Q3 FY26 and nine months ended December 31, 2025, as required under SEBI (LODR) Regulation 47. The ads were published in Business Standard (English) on February 16, 2026, and Andhra Prabha (Telugu) on February 15, 2026. The results were reviewed by the Audit Committee and approved by the Board on February 14, 2026, with statutory auditors issuing an unmodified limited review opinion. Key numbers: Q3 FY26 total income from operations fell to Rs 327.88 lakhs (vs Rs 559.05 lakhs in Q3 FY25), and the company swung to a Q3 net loss of Rs 48.45 lakhs from a profit of Rs 152.05 lakhs a year earlier. For 9M FY26, the company posted a net loss of Rs 152.65 lakhs against a profit of Rs 16.35 lakhs in 9M FY25. The company has also opted for the lower tax rate under Section 115BAA of the Income-tax Act.
This is a routine regulatory newspaper-publication filing, not a new announcement. However, the underlying results are weak — the company has slipped from a profit to a loss both for the quarter and on a nine-month basis, with revenues also declining sharply year-on-year. Retail investors should view the weak operating performance negatively, though no immediate corporate action or price trigger is attached to this filing.